Related Experiment Video

Updated: May 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Update on the management of atrial fibrillation

John V Amerena1, Tomos E Walters, Sam Mirzaee

  • 1Geelong Cardiology Research Unit, Geelong, VIC, Australia. johnam@barwonhealth.org.au.

The Medical Journal of Australia
|November 5, 2013
PubMed

Insights

Atrial fibrillation (AF) management involves controlling heart rhythm or rate and considering stroke risk. Anticoagulation, especially with newer oral agents, is crucial for stroke prevention in AF patients with higher risk scores.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia, increasing with age.
  • AF presence significantly impacts future stroke risk management.
  • Irregular pulse necessitates electrocardiogram (ECG) for diagnosis.

Purpose of the Study:

  • To outline key management decisions in atrial fibrillation.
  • To discuss rhythm control versus rate control strategies.
  • To emphasize stroke risk assessment and anticoagulation in AF.

Main Methods:

  • Review of current guidelines and evidence for AF management.
  • Assessment of stroke risk using CHADS 2 score.
  • Comparison of anticoagulation strategies, including warfarin and novel oral anticoagulants (NOACs).

Main Results:

  • Rhythm control aims for symptom improvement; AF ablation is an option for select younger patients.
  • Anticoagulation is indicated for AF patients with a CHADS 2 score ≥ 2, irrespective of AF type.
  • NOACs demonstrate comparable efficacy to warfarin for stroke prevention with a potentially improved safety profile, especially regarding intracranial bleeding.

Conclusions:

  • Effective management of atrial fibrillation requires individualized strategies for rate/rhythm control and stroke prevention.
  • Anticoagulation is a cornerstone of AF management to mitigate stroke risk, with NOACs offering a favorable safety and efficacy profile.
  • The benefits of stroke reduction with anticoagulation generally outweigh bleeding risks in most AF patients.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

21.6K

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
599
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
691
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
599